German Society for Regulatory Affairs

The Deutsche Gesellschaft für Regulatory Affairs (DGRA) — the German Society for Regulatory Affairs — is a scientific professional society in the field of pharmaceutical drug approval and regulatory affairs. It was founded in 1998 and is a registered association (eingetragener Verein) headquartered in Bonn, Germany. Its stated purpose is to create a platform for interdisciplinary communication between academia, industry and regulatory authorities, and to provide education, training and continuing professional development in the Regulatory Affairs discipline. The society serves as a communication platform for employees of regulatory affairs departments in the pharmaceutical industry, for authorities and for scientific institutions. Members and interested parties can further their education on Drug Regulatory Affairs topics by taking part in workshops, intensive seminars and the annual congress. The DGRA also organizes formats such as DGRA-Workshops, DGRA-Lunch & Learn and DGRA-Schools, and it publishes information about its office (Geschäftsstelle), membership, and prizes and scholarships. In cooperation with the University of Bonn, the DGRA runs a continuing, part-time degree programme leading to a Master of Drug Regulatory Affairs (M.D.R.A.). Since February 2011 this programme has been accredited according to the Bologna criteria by the Akkreditierungsrat (Foundation for the Accreditation of Study Programmes in Germany). The DGRA awards several honours: the Walter Cyran Medal, presented at the annual congress to a person who has rendered outstanding service to Regulatory Affairs at national or international level, with an associated prize money; the DGRA-Förderpreis for outstanding scientific work in Regulatory Affairs, endowed with EUR 5,000; and the DGRA-Studienpreis for the best master's thesis or theses from the Master of Drug Regulatory Affairs programme, endowed with EUR 1,000. As a voluntary, non-profit scientific association rather than a commercial company, the DGRA operates as a membership organization. Its governance includes a board (Vorstand) elected by the membership assembly for a four-year term; the society reported the election of a new board at its membership assembly on 18 June 2026.

The Deutsche Gesellschaft für Regulatory Affairs (DGRA) was founded in 1998 as a scientific professional society in the field of pharmaceutical drug approval. It is a registered association (eingetragener Verein) with its seat in Bonn, Germany. From its inception, its main goals have been to create a platform for interdisciplinary communication between universities, industry and authorities, and to support education, training and continuing professional development in the Regulatory Affairs discipline. Over the years the DGRA has built a programme of continuing education for its members and other interested professionals, including workshops, intensive seminars and an annual congress (Jahreskongress), as well as formats such as DGRA-Lunch & Learn and DGRA-Schools. It also functions as a communication platform for employees of regulatory affairs departments in the pharmaceutical industry, for authorities and for scientific institutions. A central element of the society's activity is its cooperation with the University of Bonn on a continuing, part-time degree programme leading to a Master of Drug Regulatory Affairs (M.D.R.A.). Since February 2011, this programme has been accredited according to the Bologna criteria by the Akkreditierungsrat (Foundation for the Accreditation of Study Programmes in Germany). The DGRA also recognizes achievement in the field through several awards. The Walter Cyran Medal is presented at the annual congress to a person who has rendered outstanding service to Regulatory Affairs at national or international level, and carries prize money. The DGRA-Förderpreis honours outstanding scientific work in Regulatory Affairs and is endowed with EUR 5,000. The DGRA-Studienpreis is awarded for the best master's thesis or theses from the Master of Drug Regulatory Affairs programme and is endowed with EUR 1,000. As a voluntary association, the DGRA is governed by a board (Vorstand) elected by its membership assembly for a four-year term. At the membership assembly on 18 June 2026, members elected a new board for the coming term, and the society thanked the departing board members for their long-standing service.

• 2026

  At the membership assembly on 18 June 2026, members elect a new board for the coming four-year term.

• 2011

  The Master of Drug Regulatory Affairs programme with the University of Bonn is accredited according to Bologna criteria by the Akkreditierungsrat.

• 1998

  DGRA founded as a scientific professional society and registered association with seat in Bonn.

A non-profit scientific professional society and communication platform linking academia, pharmaceutical industry and regulatory authorities in the German-speaking Drug Regulatory Affairs field.

• Master of Drug Regulatory Affairs (M.D.R.A.)

  Continuing, part-time degree programme run in cooperation with the University of Bonn; accredited according to Bologna criteria since February 2011.

• DGRA Annual Congress (Jahreskongress)

  Annual congress for members and interested parties on Drug Regulatory Affairs topics; also the venue for the Walter Cyran Medal award.

• DGRA-Workshops and intensive seminars

  Continuing education formats on Drug Regulatory Affairs topics.

• DGRA-Lunch & Learn

  A DGRA continuing education and exchange format.

• DGRA-Schools

  A DGRA continuing education format.

1. 1Startseite der DGRAdgra.de
2. 2Deutsche Gesellschaft für Regulatory Affairs – Wikidatawikidata.org
3. 3Deutsche Gesellschaft für Regulatory Affairs – Wikipedia (German)de.wikipedia.org